Lmr Partners LLP Tg Therapeutics, Inc. Transaction History

Lmr Partners LLP

$10.2 Billion
Q2 2024

A detailed history of Lmr Partners LLP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 10,000 shares of TGTX stock, worth $238,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,000

Holding current value

$238,299

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $133,200 - $191,900	10,000 New	10,000 $177,000
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $45,700 - $84,000	10,000 New	10,000 $59,000

Others Institutions Holding TGTX

# of Institutions

287

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

Vanguard Group Inc Valley Forge, PA

13.7M
Shares

$326 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$271 Million
0.0% of portfolio
State Street Corp Boston, MA

6.7M
Shares

$160 Million
0.01% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.65M
Shares

$86.9 Million
6.57% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.24M
Shares

$77.3 Million
0.07% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.46B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account